協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/10/05 | 3,835 | 3,875 | 3,740 | 3,775 | -155 | -3.9% | 1,109,000 |
| 2021/10/04 | 4,020 | 4,075 | 3,920 | 3,930 | -70 | -1.8% | 988,000 |
| 2021/10/01 | 4,080 | 4,080 | 3,970 | 4,000 | -25 | -0.6% | 962,600 |
| 2021/09/30 | 4,065 | 4,105 | 3,980 | 4,025 | -5 | -0.1% | 1,710,200 |
| 2021/09/29 | 4,035 | 4,090 | 4,000 | 4,030 | -75 | -1.8% | 1,044,400 |
| 2021/09/28 | 4,120 | 4,145 | 4,075 | 4,105 | -80 | -1.9% | 954,100 |
| 2021/09/27 | 4,205 | 4,240 | 4,185 | 4,185 | -25 | -0.6% | 669,500 |
| 2021/09/24 | 4,155 | 4,235 | 4,145 | 4,210 | +105 | +2.6% | 833,600 |
| 2021/09/22 | 4,110 | 4,145 | 4,060 | 4,105 | -25 | -0.6% | 691,500 |
| 2021/09/21 | 4,120 | 4,165 | 4,075 | 4,130 | +30 | +0.7% | 893,800 |
| 2021/09/17 | 4,075 | 4,120 | 4,040 | 4,100 | +20 | +0.5% | 1,078,000 |
| 2021/09/16 | 4,070 | 4,085 | 4,025 | 4,080 | ±0 | ±0% | 645,800 |
| 2021/09/15 | 4,085 | 4,090 | 4,045 | 4,080 | -10 | -0.2% | 587,900 |
| 2021/09/14 | 4,090 | 4,165 | 4,060 | 4,090 | +35 | +0.9% | 855,300 |
| 2021/09/13 | 4,035 | 4,065 | 3,985 | 4,055 | +20 | +0.5% | 650,100 |
| 2021/09/10 | 3,995 | 4,040 | 3,975 | 4,035 | +20 | +0.5% | 1,088,500 |
| 2021/09/09 | 4,040 | 4,070 | 3,980 | 4,015 | -60 | -1.5% | 791,400 |
| 2021/09/08 | 3,985 | 4,075 | 3,985 | 4,075 | +50 | +1.2% | 1,271,300 |
| 2021/09/07 | 4,000 | 4,080 | 3,980 | 4,025 | +60 | +1.5% | 1,304,800 |
| 2021/09/06 | 3,945 | 4,005 | 3,925 | 3,965 | +90 | +2.3% | 1,183,700 |
| 2021/09/03 | 3,770 | 3,880 | 3,745 | 3,875 | +95 | +2.5% | 932,600 |
| 2021/09/02 | 3,810 | 3,825 | 3,735 | 3,780 | +80 | +2.2% | 942,600 |
| 2021/09/01 | 3,655 | 3,700 | 3,625 | 3,700 | +105 | +2.9% | 810,800 |
| 2021/08/31 | 3,525 | 3,600 | 3,500 | 3,595 | +45 | +1.3% | 975,500 |
| 2021/08/30 | 3,570 | 3,580 | 3,500 | 3,550 | ±0 | ±0% | 594,900 |
| 2021/08/27 | 3,600 | 3,600 | 3,530 | 3,550 | -50 | -1.4% | 612,700 |
| 2021/08/26 | 3,620 | 3,620 | 3,570 | 3,600 | -15 | -0.4% | 566,900 |
| 2021/08/25 | 3,630 | 3,630 | 3,585 | 3,615 | -30 | -0.8% | 462,400 |
| 2021/08/24 | 3,635 | 3,650 | 3,580 | 3,645 | ±0 | ±0% | 583,900 |
| 2021/08/23 | 3,635 | 3,655 | 3,595 | 3,645 | +55 | +1.5% | 795,500 |
| 2021/08/20 | 3,590 | 3,635 | 3,570 | 3,590 | +5 | +0.1% | 768,300 |
| 2021/08/19 | 3,510 | 3,600 | 3,505 | 3,585 | +70 | +2% | 817,900 |
| 2021/08/18 | 3,505 | 3,550 | 3,485 | 3,515 | +65 | +1.9% | 872,700 |
| 2021/08/17 | 3,425 | 3,465 | 3,395 | 3,450 | +25 | +0.7% | 679,600 |
| 2021/08/16 | 3,425 | 3,460 | 3,405 | 3,425 | -35 | -1% | 533,500 |
| 2021/08/13 | 3,525 | 3,525 | 3,460 | 3,460 | -45 | -1.3% | 599,400 |
| 2021/08/12 | 3,550 | 3,565 | 3,505 | 3,505 | ±0 | ±0% | 614,800 |
| 2021/08/11 | 3,540 | 3,565 | 3,480 | 3,505 | -30 | -0.8% | 719,900 |
| 2021/08/10 | 3,475 | 3,555 | 3,460 | 3,535 | +75 | +2.2% | 761,800 |
| 2021/08/06 | 3,425 | 3,485 | 3,425 | 3,460 | +35 | +1% | 684,300 |
| 2021/08/05 | 3,460 | 3,460 | 3,390 | 3,425 | -45 | -1.3% | 821,400 |
| 2021/08/04 | 3,335 | 3,500 | 3,320 | 3,470 | -40 | -1.1% | 1,938,800 |
| 2021/08/03 | 3,535 | 3,545 | 3,480 | 3,510 | -70 | -2% | 1,082,600 |
| 2021/08/02 | 3,550 | 3,600 | 3,535 | 3,580 | +25 | +0.7% | 698,000 |
| 2021/07/30 | 3,580 | 3,595 | 3,540 | 3,555 | -95 | -2.6% | 1,070,700 |
| 2021/07/29 | 3,635 | 3,670 | 3,605 | 3,650 | +35 | +1% | 3,893,700 |
| 2021/07/28 | 3,675 | 3,680 | 3,595 | 3,615 | -70 | -1.9% | 1,156,700 |
| 2021/07/27 | 3,685 | 3,725 | 3,635 | 3,685 | -50 | -1.3% | 1,205,100 |
| 2021/07/26 | 3,820 | 3,820 | 3,725 | 3,735 | +10 | +0.3% | 1,393,200 |
| 2021/07/21 | 3,795 | 3,805 | 3,700 | 3,725 | -70 | -1.8% | 972,300 |
951～
1000
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,000円 | -3.5% | -11.3% | 2.28% | 24.16倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 167,700円 | +0.9% | +380.2% | 4.65% | 23.10倍 | 1.99倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 259,800円 | +20.9% | +10.6% | 2.54% | 12.28倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 463,500円 | +0.1% | -3.4% | 3.45% | 31.51倍 | 1.55倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,500円 | +0.6% | +43.3% | 4.80% | 11.68倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
